(Q34524547)

2 August 2017

1 reference

title

Clinical pharmacokinetics and pharmacodynamics of repaglinide (English)

1 reference

2 August 2017

1 reference

1 reference

Vibeke Hatorp

1

1 reference

2 August 2017

publication date

1 January 2002

1 reference

Clinical Pharmacokinetics

2 August 2017

published in

1 reference

2 August 2017

volume

41

1 reference

2 August 2017

issue

7

1 reference

2 August 2017

page(s)

471-483

1 reference

Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects.

2 August 2017

cites work

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics, and dose-response relationship of repaglinide in type 2 diabetes.

1 reference

12 December 2020

Effect of cimetidine on hepatic cytochrome P450: evidence for formation of a metabolite-intermediate complex

1 reference

12 December 2020

A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.

1 reference

12 December 2020

The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma

1 reference

12 December 2020

[The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984]

1 reference

12 December 2020

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

1 reference

12 December 2020

Meglitinide analogues in the treatment of type 2 diabetes mellitus

1 reference

12 December 2020

Drug interaction studies with repaglinide: repaglinide on digoxin or theophylline pharmacokinetics and cimetidine on repaglinide pharmacokinetics

1 reference

12 December 2020

Pharmacokinetic profiles of repaglinide in elderly subjects with type 2 diabetes

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

Response of non-insulin-dependent diabetic patients to an intensive program of diet and exercise.

1 reference

12 December 2020

Rifampin decreases the plasma concentrations and effects of repaglinide

1 reference

12 December 2020

Flexible prandial glucose regulation with repaglinide in patients with type 2 diabetes.

1 reference

12 December 2020

Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes

1 reference

12 December 2020

Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine

1 reference

12 December 2020

Protein binding drug displacement interactions fact or fiction?

1 reference

12 December 2020

The human hepatic cytochromes P450 involved in drug metabolism

1 reference

12 December 2020

Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.

1 reference

12 December 2020

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

1 reference

12 December 2020

Clinical Pharmacokinetics of Digoxin

1 reference

12 December 2020

Repaglinide pharmacokinetics in healthy young adult and elderly subjects

1 reference

12 December 2020

Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.

1 reference

12 December 2020

Protein binding and drug clearance

1 reference

12 December 2020

Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.

1 reference

12 December 2020

The pathogenesis of type II diabetes mellitus. A polygenic disease

1 reference

12 December 2020

Dosage of Theophylline in Bronchial Asthma

1 reference

12 December 2020

Absorption, metabolism and excretion of a single oral dose of (14)C-repaglinide during repaglinide multiple dosing

1 reference

12 December 2020

Effects of the hypoglycaemic drugs repaglinide and glibenclamide on ATP-sensitive potassium-channels and cytosolic calcium levels in beta TC3 cells and rat pancreatic beta cells

1 reference

12 December 2020

Single-dose pharmacokinetics of repaglinide in subjects with chronic liver disease.

1 reference

12 December 2020

Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes

1 reference

12 December 2020

Substrates of human hepatic cytochrome P450 3A4.

1 reference

12 December 2020

Pharmacokinetics of repaglinide in subjects with renal impairment

1 reference

12 December 2020

10.2165/00003088-200241070-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1023462539

0 references

1 reference